Company profile: Acceptys
1.1 - Company Overview
Company description
- Provider of human antibody therapies targeting cancer and infectious diseases, offering anti-cancer and anti-viral human antibodies for lung, pancreatic, gastric, and colon cancers. Founded in 2002 and based in Sparta, New Jersey.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Acceptys
Xyphos
HQ: United States
Website
- Description: Provider of CAR-T cell therapy platforms for treating relapsed hematological malignancies and solid tumors. Offers ACCEL, which uses engineered ligands to precisely control activity and targeting of universal convertibleCAR-T with tumor-specific antibodies, and ConvertibleCAR, a technology modifying NKG2D to enable flexible multi-antigen targeting and enhanced immune cell activation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xyphos company profile →
MacroGenics
HQ: United States
Website
- Description: Provider of immunotherapeutics, including antibody-drug conjugates and DART bispecifics targeting B7-H3, PD-1×CTLA-4 and CD123, to treat metastatic castration-resistant prostate cancer, advanced solid tumors, CD123-positive neoplasms (AML, MDS) and multiple cancers; programs include vobramitamab duocarmazine, lorigerlimab, MGD024, MGC026, MGC028 and enoblituzumab.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MacroGenics company profile →
Medicago
HQ: Canada
Website
- Description: Provider of vaccines in Canada, leveraging proprietary plant-based Proficia and Virus-Like Particles (VLP) technologies; focuses on the research, development, production, and commercialization of vaccines, with product candidates including an H5N1 pandemic candidate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medicago company profile →
Harpoon Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage immunotherapy developing novel T cell-engaging biologic therapies that harness the body’s immune system to direct patients’ T cells to kill target cells in cancer and other diseases, including the TriTAC Technology antibody-based drug discovery platform designed to enhance immune targeting and killing of cancer cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Harpoon Therapeutics company profile →
XBiotech
HQ: United States
Website
- Description: Provider of antibody therapy development as a biopharmaceutical company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XBiotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Acceptys
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Acceptys
2.2 - Growth funds investing in similar companies to Acceptys
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Acceptys
4.2 - Public trading comparable groups for Acceptys
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →